COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

202304_Blog_Suspendit_1768x923.jpg

We’re reviewing the distinctions between SuspendIt and SuspendIt Anhydrous, as well as how revisions to USP Chapter 795 will guide beyond use dates (BUDs) for aqueous and nonaqueous oral dosage forms.

202301_Blog_NewProd_1768x923.jpg

PCCA Director of Formulations Melissa Merrell Rhoads, PharmD, offers insights on working with SuspendIt Anhydrous in oral suspension formulations